SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding the Fairness of the Sale of Vitae Pharmaceutica...
September 15 2016 - 10:43AM
Business Wire
The following statement is being issued by Levi & Korsinsky,
LLP:
To: All Persons or Entities who purchased Vitae
Pharmaceuticals, Inc. (“Vitae Pharmaceuticals”) (NASDAQ:
VTAE) stock prior to September 14,
2016.
You are hereby notified that Levi & Korsinsky, LLP
has commenced an investigation into the fairness of the
sale of Vitae Pharmaceuticals to Allergan plc for $21.00 per
share. The transaction has a total approximate value of $639
million. To learn more about the action and your rights, go
to:
http://zlk.9nl.com/vitae-pharmaceuticals-vtae
or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972. There is no cost or obligation to you.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut, California, and Washington D.C. The
firm’s attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities lawsuits and have recovered
hundreds of millions of dollars for aggrieved shareholders. For
more information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160915005921/en/
Levi & Korsinsky, LLPJoseph E. Levi, Esq.Eduard Korsinsky,
Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax:
212-363-7171www.zlk.com
VITAE PHARMACEUTICALS, INC (NASDAQ:VTAE)
Historical Stock Chart
From Mar 2024 to Apr 2024
VITAE PHARMACEUTICALS, INC (NASDAQ:VTAE)
Historical Stock Chart
From Apr 2023 to Apr 2024